Altogether, our results suggest that there is a complex and a strong interaction between genetic variation in the HLA region, the presence of anti-Ro/SSA antibodies and the IFN-epigenetic signature observed in SS. The gene discussed is IFNA1; the disease is synovial sarcoma.